Presidential Documents

Federal Register / Vol. 88, No. 212 / Friday, November 3, 2023 / Presidential Documents 75457 

Proclamation 10663 of October 31, 2023 

National Diabetes Month, 2023 

By the President of the United States of America 

A Proclamation 

One in ten Americans has diabetes, and of that group, one in five of them 

do not know that they do. While this chronic condition is becoming more 

common, there is so much that we can do to help prevent and manage 

it. During National Diabetes Month, we recommit as a Nation to making 

treatment more affordable, improving care, and finally finding a cure. 

Every day, millions of Americans with diabetes struggle to afford life-saving 

insulin. It costs drug companies just $10 a vial to produce, but some charge 

more than 30 times that amount. Americans across the country have told 

me how those high prices sometimes force them to ration their medication, 

too often resulting in dangerous health complications that could have been 

avoided. Too many of them know what it is like to lay awake at night, 

staring at the ceiling, wondering how to choose between putting food on 

the table and buying the insulin they need to stay alive. It is wrong. 

I ran for President to rebuild the middle class—and that includes working 

to make health care a right in this country, not a privilege. For decades, 

big pharmaceutical companies have blocked efforts to lower prescription 

drug costs, but together, we took them on and won. Last year, I signed 

the Inflation Reduction Act, one of the most significant laws ever passed 

to reduce prescription drug prices, capping insulin at $35 per month for 

seniors on Medicare, down from as much as $400 per month. The Inflation 

Reduction Act finally gave Medicare the ability to negotiate for lower drug 

prices, starting this year with ten drugs—including treatments for diabetes— 

benefiting more than nine million Americans. The law also requires drug 

companies that raise prices faster than inflation to pay the difference back 

to the Government, saving seniors up to $618 per dose of medication. 

Seniors and other Part D enrollees with high drug spending will have 

their out-of-pocket drug costs capped at about $3,500 next year. In 2025, 

the Inflation Reduction Act will cap total out-of-pocket drug costs for all 

seniors on Medicare at $2,000 per year, period. There is more to do, but 

these steps will put money back in the pockets of millions of families, 

easing fears and giving them just a little more breathing room. 

While we keep working to make diabetes medications more affordable, my 

Administration is also focused on prevention, early interventions, improving 

treatments, and finding a cure. Today, one in three American adults has 

prediabetes, with a risk of developing Type 2 diabetes within 5 years. 

Diabetes has serious consequences. It is a leading cause of death in the 

United States, and once diagnosed, increases one’s risk of heart attack, 

stroke, blindness, kidney failure, and loss of toes, feet, or legs. It is important 

to be aware of diabetes risk factors, many of which relate to nutrition 

and physical activity deficits. To learn more about risk factors and how 

to combat prediabetes, visit the Centers for Disease Control and Prevention 

National Diabetes Prevention Program: https://www.cdc.gov/diabetes/prevention/index.html. 


lotter on DSK11XQN23PROD with FR_PREZDOC3
75458 Federal Register / Vol. 88, No. 212 / Friday, November 3, 2023 / Presidential Documents 

Last year, we launched the Advanced Research Project Agency for Health 

(ARPA–H) to drive breakthroughs in preventing, detecting, and treating deadly diseases, including diabetes. Research advances have already helped develop several new diabetes drugs, including the first that can delay the 

onset of Type 1 diabetes, giving recently diagnosed people more time before 

starting insulin. This year, the Food and Drug Administration also approved 

the first cell therapy for adults with Type 1 diabetes who cannot safely 

manage their glucose levels with insulin as well as the first new oral medication for children with Type 2 diabetes in over two decades. We remain 

committed to robust research investment and to providing pathways to drive 

the development and delivery of additional, effective treatments and muchneeded cures. 

At the same time, we have expanded health coverage nationwide and lowered 

health care costs for millions of Americans, including the nearly 15 million 

Americans who buy their coverage under the Affordable Care Act and are 

saving $800 per year on their premiums. We are also cracking down on 

surprise medical bills and junk health insurance plans that look affordable 

but then stick consumers with big hidden costs. Last year, we held the 

first White House Conference on Hunger, Nutrition, and Health in over 

50 years where we convened advocates, health care providers, food companies, and officials from every level of government. We have laid out a 

vision to prevent and reduce the pervasiveness of diet-related disease, like 

diabetes, across the United States by 2030, outlining a comprehensive strategy 

to end hunger and put healthy food on the table. Our plan incorporates 

steps to better prevent and manage diabetes, including by expanding access 

to nutrition counseling and working with the Congress to make the Medicare 

Diabetes Prevention Program permanent. 

We want all 37 million Americans with diabetes to know that we have 

their backs and that the historic progress we have made to lower insulin 

prices is just the first step. This month, we celebrate the courage and 

resilience of this community; and we honor the medical professionals, loved 

ones, and advocates who do so much to help support it and keep driving 

us toward a cure. 

NOW, THEREFORE, I, JOSEPH R. BIDEN JR., President of the United States 

of America, by virtue of the authority vested in me by the Constitution 

and the laws of the United States, do hereby proclaim the month of November 

2023 as National Diabetes Month. I call upon all Americans, school systems, 

government agencies, nonprofit organizations, health care providers, research 

institutions, and other interested groups to join in activities that raise diabetes 

awareness and help prevent, treat, and manage this disease. 


lotter on DSK11XQN23PROD with FR_PREZDOC3
Federal Register / Vol. 88, No. 212 / Friday, November 3, 2023 / Presidential Documents 75459 

IN WITNESS WHEREOF, I have hereunto set my hand this thirty-first day 

of October, in the year of our Lord two thousand twenty-three, and of 

the Independence of the United States of America the two hundred and 

forty-eighth. 

[FR Doc. 2023–24497 

Filed 11–2–23; 8:45 am] 

Billing code 3395–F4–P 


lotter on DSK11XQN23PROD with FR_PREZDOC3BIDEN.EPS</GPH>